We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Lars Lund

Lars H Lund MD, PhD

Associate Professor in the Department of Medicine, Karolinska Institutet, and Senior Consultant in the Department of Cardiology, Karolinska University Hospital

Lars H Lund, MD PhD, is an Associate Professor in the Department of Medicine, Karolinska Institutet, and Senior Consultant in the Department of Cardiology, Karolinska University Hospital. He trained in medicine, cardiology and heart failure at Duke University and Columbia University. His expertise is HF big data and registry-based comparative outcomes studies and pragmatic trials. He is active in programs to improve utilization of existing evidence based interventions in heart failure with reduced ejection fraction, as well as in novel interventions and pragmatic trials of new use applications of existing drugs in heart failure with preserved ejection fraction. He has extensive experience and leadership positions in heart failure registries: He is Associate Director of the Swedish Heart Failure Registry (SwedeHF) Research Program; a board member of the Heart Failure Association (HFA) and a member of the working group for the HFA European Heart Failure Registry of the ESC Observational Research Program (EORP); Associate Director the International Society for Heart & Lung Transplantation (ISHLT) Registry, and on the Steering Committee of the ISHLT International Registry for Mechanical Circulatory Support (IMACS). He is on steering committees for several trials and observational studies. He is or has been Associate Editor for and on the Editorial Boards of numerous journals including Circulation, European Journal of Heart Failure and Journal of Cardiac Failure. He has over 130 publications in peer reviewed journals, an H-index of 28, and one patent.

Recent Contributions to PracticeUpdate:

  1. Heart Failure Associated With Current Use of NSAIDs